Home

Terapio is a biopharmaceutical company developing therapeutics based on the RLIP76 protein. Initial applications include developing the RLIP76 protein as a medical countermeasure for radiation exposure and chemical threats to civilian, military, and first responder populations. The RLIP76 protein primarily works though the oxidative stress pathway and provides benefit as both a prophylactic and post exposure treatment.

Terapio

/Tĕ•rah•pē•ō/

means therapy in Esperanto, an international, constructed language introduced by Dr. L.L. Zamenhof in 1887.

Contact Us

Terapio Corporation

11412 Bee Cave Rd, Suite 100
Austin, Texas 78738
512.697.8179
(f) 512.287.4241
contact.terapio@terapio.com